
Abbey Drugs Private Limited
About Abbey Drugs Private Limited
Data last updated:
Abbey Drugs Private Limited is a private limited company based in Chandigarh, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 18 January 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24233CH2001PTC024174. Its GSTIN is 04AAECA8469L1ZA (Chandigarh).
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Ashwani Kumar Khunger and Sunita Khunger.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 36/5 1st Floor Rear Cabin No. 1 Adarsh Nagar Pipliwala Town Manimajra, Chd (UT), Chandigarh, India – 160101.
As per the financials filed for FY 2024, the company reported a revenue of ₹60.36 Lakh, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹83,094 (net margin 1.4%) and EBITDA of ₹4.65 Lakh (EBITDA margin 7.7%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 11% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Abbey Drugs Private Limited's registered office is in Chandigarh, Chandigarh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No. 36/5 1st Floor Rear Cabin No. 1 Adarsh Nagar Pipliwala Town Manimajra, Chd (UT), Chandigarh, India – 160101
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Abbey Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Abbey Drugs is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Abbey Drugs Private Limited, buy the company report.
Financials of Abbey Drugs Private Limited
FY 2025 filings availableAbbey Drugs Private Limited reported revenue of ₹60.36 Lakh (up 4% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 4% growth in the latest year. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.65 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹83,094 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.7% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Abbey Drugs Private Limited, buy the company report.
Board of directors of Abbey Drugs Private Limited
Abbey Drugs has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashwani Kumar Khunger | Director | 18 Jan 2001 | 25 Years 10 Months | Current |
| Sunita Khunger | Director | 30 Mar 2005 | 21 Years 7 Months | Current |
| Anuja Daga | Additional Director | 25 Sep 2020 | 6 Years 1 Months | Current |
Peer comparison
Abbey Drugs Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| HR Automotives Private Limited | ₹60.39 Lakh (FY 2025) | 2607.0% | Siliguri, West Bengal, India | |||
| Sangam Vyapaar Pvt Ltd | ₹60.38 Lakh (FY 2025) | 232.0% | Kolkata, West Bengal, India | |||
| Payal Cables Private Limited | ₹60.37 Lakh (FY 2025) | 5.0% | New Delhi, Delhi, India | |||
| Agile Tradecom Private Limited | ₹60.37 Lakh (FY 2025) | -49.0% | Kolkata, West Bengal, India | |||
| Agnik Trade Enterprises Private Limited | ₹60.37 Lakh (FY 2022) | Kolkata, West Bengal, India | ||||
| Abbey Drugs Private Limitedthis company | ₹60.36 Lakh (FY 2024) | ₹83,094 | 1.4% | 4.0% | Chandigarh, India | |
| Harjivandas Gordhandas and Company Limited | ₹60.36 Lakh (FY 2025) | 36.0% | Mumbai, Maharashtra, India | |||
| Swaad of Zamindars Private Limited | ₹60.34 Lakh (FY 2019) | 5.0% | Muzaffarpur, Bihar, India | |||
| Rivoaura Private Limited | ₹60.34 Lakh (FY 2020) | 1016.0% | New Delhi, Delhi, India | |||
| Embroedge Limited | ₹60.33 Lakh (FY 2025) | -1.0% | Kolkata, West Bengal, India | |||
| Trident Vincom Private Limited | ₹60.33 Lakh (FY 2016) | -36.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Abbey Drugs Private Limited, buy the company report.
Auditor
Abbey Drugs Private Limited is audited by MALHOTRA RAJIV & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MALHOTRA RAJIV & CO | FY 2017 | 024854N |
Shareholding
The shareholding of Abbey Drugs Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Abbey Drugs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Abbey Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Abbey Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Abbey Drugs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAECA8469L1ZA | Chandigarh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Abbey Drugs Private Limited, buy the company report.
Recent activity
Abbey Drugs Private Limited has 4 board changes on record since 2001: 3 appointments and 1 cessation. The latest: Anuja Daga was appointed as Additional Director on 25 Sep 2020.
Frequently asked questions
Abbey Drugs is an active private limited company based in Chandigarh, India. The company works in wholesale, within the trading industry. It was incorporated on 18 January 2001 (25+ years old) and is registered under CIN U24233CH2001PTC024174.
Abbey Drugs has 3 current directors:
- Ashwani Kumar Khunger - Director
- Sunita Khunger - Director
- Anuja Daga - Additional Director
The latest financial statements of Abbey Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Abbey Drugs is 04AAECA8469L1ZA, registered in Chandigarh.
The CIN (Corporate Identification Number) of Abbey Drugs is U24233CH2001PTC024174. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Abbey Drugs was incorporated on 18 January 2001, making it 25+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Abbey Drugs by revenue are HR Automotives Private Limited, Sangam Vyapaar Pvt Ltd, Payal Cables Private Limited, Agile Tradecom Private Limited, Agnik Trade Enterprises Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Anuja Daga was appointed as Additional Director on 25 Sep 2020. Ravinder Garg ceased to be Director on 15 Mar 2012. Sunita Khunger was appointed as Director on 30 Mar 2005. Abbey Drugs has 4 board changes on record in total.
The registered office of Abbey Drugs is at Shop No. 365 1st Floor Rear Cabin No. 1 Adarsh Nagar Pipliwala Town Manimajra, Chd UT, Chandigarh, India – 160101.
Abbey Drugs operates in the trading industry, in the wholesale segment.
The compliance status of Abbey Drugs is compliant as of 28 July 2026. The company is actively filing with the Registrar of Companies.

